Published in
Elsevier, Kidney International Reports, 2(4), p. 257-266, 2019
DOI: 10.1016/j.ekir.2018.10.003
Links
Tools
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir in Patients With Hepatitis C Virus Genotype 1 or 4 Infection and Advanced Kidney Disease
Journal article published in 2019 by
Eric Lawitz,
Edward Gane,
Eric Cohen,
John Vierling,
Kosh Agarwal 
,
Tarek Hassanein,
Parvez S. Mantry,
Paul J. Pockros,
Michael Bennett,
Nyingi Kemmer,
Giuseppe Morelli,
Jiuhong Zha,
Deli Wang,
Nancy S. Shulman,
Daniel E. Cohen
and other authors.
,
Tarek Hassanein,
Parvez S. Mantry,
Paul J. Pockros,
Michael Bennett,
Nyingi Kemmer,
Giuseppe Morelli,
Jiuhong Zha,
Deli Wang,
Nancy S. Shulman,
Daniel E. Cohen
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 